Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Daily News

New Biomarker-Based Risk Score Performs Well in ACS

Michael O'Riordan

October 25, 2022

News Daily News

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

Michael O'Riordan

September 15, 2022

News Daily News

After COVID-19, Unvaccinated at Risk for Long-term CVD Complications

Michael O'Riordan

August 16, 2022

News Daily News

Genetic Study Hints at Cognitive Impact of Statins, but Experts Urge Caution

Michael O'Riordan

August 11, 2022

News Daily News

CABG Bests PCI in Patients With Good Physical, Mental Health: SYNTAXES

Michael O'Riordan

July 22, 2022

News Daily News

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

Michael O'Riordan

July 11, 2022

News Daily News

Higher Single-Sample hs-cTnT Threshold Can Safely Exclude MI

Michael O'Riordan

May 13, 2022

News Daily News

Acute MI Workup in Emergency Departments Varies by Sex and Race

Michael O'Riordan

May 11, 2022

News Daily News

British Medical Groups Express Concern About Inclisiran Rollout

Michael O'Riordan

December 14, 2021

News Daily News

Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis

Michael O'Riordan

February 10, 2020

News Daily News

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

Michael O'Riordan

January 03, 2020

News Daily News

One in Five ACS Patients Does Not Fill P2Y12 Inhibitor Prescription After PCI

Michael O'Riordan

May 21, 2018

News Daily News

Women Underrepresented in Pivotal Studies Leading to FDA Drug Approval

Michael O'Riordan

May 01, 2018

News Daily News

TCTMD’s Top 10 Most Popular Stories for September 2016

Shelley Wood

September 30, 2016

News Daily News

Pharmacist Management of High Cholesterol Gets More Patients to Goal, Lowers LDL Levels: RxACT

Michael O'Riordan

September 29, 2016

News Daily News

Nearly 40% of Diabetic Patients Not Treated With Statins: PINNACLE Registry

Michael O'Riordan

September 13, 2016

News Daily News

Aspirin App Pairs Clinical Studies With Technology to Balance Bleeding, Benefits

Michael H. Wilson

June 27, 2016

Advertisement

New Biomarker-Based Risk Score Performs Well in ACS

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

After COVID-19, Unvaccinated at Risk for Long-term CVD Complications

Genetic Study Hints at Cognitive Impact of Statins, but Experts Urge Caution

CABG Bests PCI in Patients With Good Physical, Mental Health: SYNTAXES

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

Higher Single-Sample hs-cTnT Threshold Can Safely Exclude MI

Acute MI Workup in Emergency Departments Varies by Sex and Race

British Medical Groups Express Concern About Inclisiran Rollout

Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

One in Five ACS Patients Does Not Fill P2Y12 Inhibitor Prescription After PCI

Women Underrepresented in Pivotal Studies Leading to FDA Drug Approval

TCTMD’s Top 10 Most Popular Stories for September 2016

Pharmacist Management of High Cholesterol Gets More Patients to Goal, Lowers LDL Levels: RxACT

Nearly 40% of Diabetic Patients Not Treated With Statins: PINNACLE Registry

Aspirin App Pairs Clinical Studies With Technology to Balance Bleeding, Benefits

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content